Topic Archives: Sociedad Quimica y Minera de Chile (SQM)

I love this story… it brings to mind the Indiana Jones-style teaser pitches about top-secret mineral riches in strange places that were so prevalent a decade ago in newsletterland… here’s a little taste: “This Secret Research Complex… “Hidden Away in a Small Town in Australia… “Is About to Reveal a “$66 Billion Breakthrough…” Wow, so […]

First Published March 8 2016 This is not a brand-new ad, and it has been discussed by Gumshoe readers a few times — but apparently I’ve never written about it or looked closely at it, so we’ll remedy that today. And, of course, we’ll name the “secret” stocks being teased for you. Keith Kohl opens […]

This teaser for one of Andy Obermueller’s newsletters has been making the rounds for a while, but it has so many aggressive predictions in it that the questions about it roll in to Stock Gumshoe HQ pretty regularly … so let’s see if we can pick out a few of his hot “investment opportunities,” shall […]

Comments

  • Dr. KSS MD PhD

    I've seen few scenarios as embittering as PTN. I just believe mgmt told whopper-size lies to shareholders and we still d...

  • Dr. KSS MD PhD

    A $PTN buyout is plausible. Flibanserin (Addyi) was recently approved for FSD and bought by Valeant....

  • Avatar

    $PTN - - some observations from the presentation. > Slide 7: "Market analysts estimate global market > $2 billi...

  • Avatar

    Bizbanx -- this link gives a version of the 19-item FSFI questionnaire that was used for both bremelanotide and for flib...

  • Avatar

    I also read that alcohol is compatible with bremelanotide whereas it's contraindicated in patients on flibanserin (Addyi...

  • Avatar

    The New York Times reports that Sprout's flibanserin - once dubbed the pink viagra - has proved less than arousing. Mar...

  • Avatar

    $PTN. Was updating myself today on this stock, which has been discussed here from time to time, and am sharing in case ...

  • Dr. KSS, MD PhD

    A most excellent point, Kenny. If one puts the best possible spin on PTN it's now easily worth more. The street view, ho...

  • Dr. KSS, MD PhD

    The couple in Raleigh, NC, who bought and developed flibanserin are quixotic. The till may have little cutter in it when...

  • Anamorph

    John Carroll at Fierce Biotech on the FDA's approval of Flibanserin: http://www.fiercebiotech.com/story/fda-blundered...

  • psvena

    And on 06/05/15: Author: Dr. KSS, MD PhD Comment: Sogiam: you were asking about Palatin. This is a pure sucker's ral...

  • Avatar

    Rae -- agree with you on the merits, but note that it is not possible to invest directly in flibanserin even if one were...

  • Avatar

    FDA statement on flibanserin approval: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm458734.htm Long $P...

  • Avatar

    Spelling correction: flibANSERIN. Hate it when that happens....

  • Avatar

    I have no medical background whatsoever, but I also strongly disagree with the acceptance of flibanserin. imo, at first...

  • Anamorph

    THE REAL PROBLEM WITH FLIBANSERIN: http://www.newyorker.com/cartoons/daily-cartoon/daily-cartoon-friday-june-5th-female...

  • Anamorph

    Interesting and very public battle going on about this drug, and the issues are at least as much politics and perception...

  • Dr. KSS, MD PhD

    Kenny: and don't doubt flibanserin therapy won't cost at least $500/month and NOT be covered by third party payers. For ...

  • Dr. KSS, MD PhD

    Kenny---I think much will depend on marketing, but I look at it this way. Flibanserin is premised on a notion that tweak...

  • Avatar

    Doc - in addition to the warning labels for flibanserin, I had read that the drug provides very modest results, specific...

  • Dr. KSS, MD PhD

    According to briefing documents, the FDA will likely require physicians intending to prescribe flibanserin for female se...

  • Dr. KSS, MD PhD

    Sogiam: you were asking about Palatin. This is a pure sucker's rally in its shares, as Sprout's flibanserin story has li...

  • Dr. KSS, MD PhD

    https://soundcloud.com/bmjpodcasts/the-sex-drug-for-women?utm_source=feedburner-bmj.com+download&utm_medium=feed&utm_cam...

  • Avatar

    Doc, thanks for your comments and I'm so glad you let the poorly informed author know about PTN. Sprout has done a good ...

  • karmaswimswami

    Frank: Thanks for asking about flibanserin. My honest view is that Boehringer was wise to divest itself of that product ...

  • frank archambeau

    Dr KSS ; as a follow up to PTN have you any thoughts on Sprout pharma 'Flibanserin' for HSDD?...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch